The present invention provides methods for using granulocyte macrophage colony-stimulating factor receptor (CDl 16) expression level for various clinical applications including, but not limited to, diagnosing inflammatory bowel disease in a subject.
申请公布号
WO2011028697(A3)
申请公布日期
2011.07.14
申请号
WO2010US47289
申请日期
2010.08.31
申请人
THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODYCORPORATE;COLGAN, SEAN, P.;GOLDSTEIN, JONATHAN
